240 related articles for article (PubMed ID: 25889065)
1. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.
Hameeduddin A; Sahdev A
Cancer Imaging; 2015 Mar; 15(1):3. PubMed ID: 25889065
[TBL] [Abstract][Full Text] [Related]
2. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
3. [New opportunities, MRI biomarkers in the evaluation of gynaecological cancer].
Horváth K; Gõdény M
Magy Onkol; 2015 Sep; 59(3):216-27. PubMed ID: 26339911
[TBL] [Abstract][Full Text] [Related]
4. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor.
Kitajima K; Tanaka U; Ueno Y; Maeda T; Suenaga Y; Takahashi S; Deguchi M; Miyahara Y; Ebina Y; Yamada H; Tsurusaki M; Tamaki Y; Sugimura K
PLoS One; 2015; 10(1):e0117411. PubMed ID: 25629156
[TBL] [Abstract][Full Text] [Related]
5. MR perfusion for pelvic female imaging.
Thomassin-Naggara I; Siles P; Balvay D; Cuenod CA; Carette MF; Bazot M
Diagn Interv Imaging; 2013 Dec; 94(12):1291-8. PubMed ID: 24183708
[TBL] [Abstract][Full Text] [Related]
6. Diffusion weighted imaging and contrast-enhanced magnetic resonance imaging in the evaluation of early stage endometrial cancer.
An Q; Ynag J; Zhu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):486-91. PubMed ID: 23134825
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of endometrial and cervical cancer.
Sahdev A; Reznek RH
Ann N Y Acad Sci; 2008 Sep; 1138():214-32. PubMed ID: 18837902
[TBL] [Abstract][Full Text] [Related]
8. Novel imaging techniques in gynaecological cancer.
Vandecaveye V; Dresen R; De Keyzer F
Curr Opin Oncol; 2017 Sep; 29(5):335-342. PubMed ID: 28594645
[TBL] [Abstract][Full Text] [Related]
9. Staging of gynecologic malignancies.
Ascher SM; Takahama J; Jha RC
Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in the diagnosis and management of endometrial and cervical carcinomas.
Tirumani SH; Shanbhogue AK; Prasad SR
Radiol Clin North Am; 2013 Nov; 51(6):1087-110. PubMed ID: 24210446
[TBL] [Abstract][Full Text] [Related]
11. Radiological assessment of gynecologic malignancies.
Bell DJ; Pannu HK
Obstet Gynecol Clin North Am; 2011 Mar; 38(1):45-68, vii. PubMed ID: 21419327
[TBL] [Abstract][Full Text] [Related]
12. Role of magnetic resonance imaging and apparent diffusion coefficient at 3T in distinguishing between adenocarcinoma of the uterine cervix and endometrium.
Lin YC; Lin G; Chen YR; Yen TC; Wang CC; Ng KK
Chang Gung Med J; 2011; 34(1):93-100. PubMed ID: 21392479
[TBL] [Abstract][Full Text] [Related]
13. [Distinguishing of scar tissue from recurrent tumor after therapy of tumors of the female pelvis].
Ebner F; Ranner G; Flückiger F
Radiologe; 1994 Jul; 34(7):384-9. PubMed ID: 7938486
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer.
Nagar H; Dobbs S; McClelland HR; Price J; McCluggage WG; Grey A
Gynecol Oncol; 2006 Nov; 103(2):431-4. PubMed ID: 16697034
[TBL] [Abstract][Full Text] [Related]
15. Imaging in gynecologic malignancies.
Bragg DG; Hricak H
Cancer; 1993 Feb; 71(4 Suppl):1648-51. PubMed ID: 8431900
[TBL] [Abstract][Full Text] [Related]
16. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of uterine malignancies.
Whitten CR; DeSouza NM
Top Magn Reson Imaging; 2006 Dec; 17(6):365-77. PubMed ID: 17417085
[TBL] [Abstract][Full Text] [Related]
18. Early cervical carcinoma and fertility-sparing treatment options: MR imaging as a tool in patient selection and a follow-up modality.
Noël P; Dubé M; Plante M; St-Laurent G
Radiographics; 2014; 34(4):1099-119. PubMed ID: 25019444
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer: magnetic resonance imaging.
Manfredi R; Gui B; Maresca G; Fanfani F; Bonomo L
Abdom Imaging; 2005; 30(5):626-36. PubMed ID: 15886951
[TBL] [Abstract][Full Text] [Related]
20. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
